Long term survival in patients with cardiac amyloidosis: Prevalence and characterisation during follow-up

Heart Lung and Circulation

Volumn 22, Issue 8, 2013, Pages 647-654

  Finocchiaro, Gherardo ^a   Merlo, Marco ^a   Pinamonti, Bruno ^a   Barbati, Giulia ^a   Santarossa, Elena ^a   Doimo, Sara ^a   Bussani, Rossana ^a   Sinagra, Gianfranco ^a  

^a UNIVERSITY OF TRIESTE   (Italy)

Author keywords

Cardiac amyloidosis; Long term survival

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ADULT; ARTICLE; CHRONIC INFLAMMATION; CLINICAL ARTICLE; CLINICAL FEATURE; DISEASE COURSE; DISEASE SEVERITY; DOPPLER ECHOCARDIOGRAPHY; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART AMYLOIDOSIS; HEART ATRIUM FIBRILLATION; HEART LEFT VENTRICLE FILLING; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE SEPTUM; HUMAN; LONG TERM SURVIVAL; M MODE ECHOCARDIOGRAPHY; MALE; MORTALITY; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; SURVIVAL RATE; SYSTOLIC DYSFUNCTION; SYSTOLIC HYPERTENSION; TWO DIMENSIONAL ECHOCARDIOGRAPHY; AGED; AMYLOIDOSIS; BLOOD PRESSURE; CLINICAL TRIAL; DISEASE FREE SURVIVAL; HEART DISEASES; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; REGISTER; RETROSPECTIVE STUDY; TIME;

AGED; AMYLOIDOSIS; BLOOD PRESSURE; DISEASE-FREE SURVIVAL; FEMALE; HEART DISEASES; HUMANS; MALE; MIDDLE AGED; PREVALENCE; REGISTRIES; RETROSPECTIVE STUDIES; SURVIVAL RATE; TIME FACTORS;

EID: 84881559232     PISSN: 14439506     EISSN: 14442892     Source Type: Journal    
DOI: 10.1016/j.hlc.2013.01.010     Document Type: Article

References (26)

1. Falk M.D. Diagnosis and management of the cardiac amyloidoses. Circulation 2005, 112:2047-2060.
2. Selvanayagam J.B., Hawkins P.N., Paul B., Myerson S.G., Neubauer S. Evaluation and management of the cardiac amyloidosis. J Am Coll Cardiol 2007, 50:2101-2110.
3. Hassan W., Al-Sergani H., Mourad W., Tabbaa R. Amyloid heart disease. New frontiers and insights in pathophysiology, diagnosis, and management. Tex Heart Inst J 2005, 32:178-184.
4. Saito M., Hayashi T., Nojima M., Ikeda H., Tarasawa I., Yasui H., et al. Long-term survival after autologous peripheral blood stem cell transplantation in a patient with primary AL amyloidosis complicating congestive. Rinsho Ketsueki 2007, 48:1478-1483.
5. Perz J.B., Kristen A.V., Rahemtulla A., Parameshwar J., Sack F.U., Apperley J.F., et al. Long-term survival in a patient with AL amyloidosis after cardiac transplantation followed by autologous stem cell transplantation. Clin Res Cardiol 2006, 95:671-674.
6. Cueto-Garcia L., Reeder G.S., Kyle R.A., Wood D.L., Seward J.B., Naessens J., et al. Echocardiographic findings in systemic amyloidosis: spectrum of cardiac involvement and relation to survival. J Am Coll Cardiol 1985, 6:737-743.
7. Rapezzi C., Merlini G., Quarta C.C., Riva L., Longhi S., Leone O., et al. Systemic cardiac amyloidoses. Disease profiles and clinical courses of the 3 main types. Circulation 2009, 120:1203-1212.
8. Dickstein K., Cohen-Solal A., Filippatos G., McMurray J.J., Ponikowski P., Poole-Wilson P.A., et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Eur J Heart Fail 2008, 10:933-989.
9. Sahn D.J., De Maria A., Kisslo J., Weyman A. The committee on M-mode standardization of the American Society of Echocardiography: recommendations regarding quantification in M-mode echocardiography. Results of a survey of echocardiographic measurements. Circulation 1988, 58:1072-1083.
10. Lang R.M., Bierig M., Devereux R.B., Flachskampf F.A., Foster E., Pellikka P.A., et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography' guidelines and standards committee and the chamber quantification writing group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005, 18:1440-1463.
11. Rudski L.G., Lai W.W., Afilalo J., Hua L., Handschumacher M.D., Chandrasekaran K., et al. Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography. J Am Soc Echocardiogr 2010, 23:685-713.
12. Nagueh S.F. Echocardiographic assessment of left ventricular relaxation and cardiac filling pressures. Curr Heart Fail Rep 2009, 6:154-159.
13. Bhave N.M., Lang R.M. Quantitative echocardiographic assessment of native mitral regurgitation: two- and three-dimensional techniques. J Heart Valve Dis 2011, 20:483-492.
14. Janda S., Shahidi N., Gin K., Swiston J. Diagnostic accuracy of echocardiography for pulmonary hypertension: a systematic review and meta-analysis. Heart 2011, 97:612-622.
15. Yu C.M., Sanderson J.E., Marwick T.H., Oh J.K. Tissue Doppler imaging a new prognosticator for cardiovascular diseases. J Am Coll Cardiol 2007, 49:1903-1914.
16. Rickam P.P. Human experimentation. Code of ethics of the World Medical Association. Declaration of Helsinki. Br Med J 1964, 18(2):177-180.
17. Austin B.A., Duffy B., Tan C., Rodriguez E.R., Starling R.C., Desai M.Y. Comparison of functional status, electrocardiographic, and echocardiographic parameters to mortality in endomyocardial-biopsy proven cardiac amyloidosis. Am J Cardiol 2009, 103:1429-1433.
18. Kristen A.V., Perz J.B., Schonland S.O., Hegenbart U., Schnabel P.A., Kristen J.H., et al. Non-invasive predictors of survival in cardiac amyloidosis. Eur J Heart Fail 2007, 9:617-624.
19. Finocchiaro G., Pinamonti B., Merlo M., Giannini F., Barbati G., Pivetta A., et al. Focus on cardiac amyloidosis: a single-center experience with a long-term follow-up. J Cardiovasc Med (Hagerstown) 2012 May 17, [Epub ahead of print].
20. Dispenzieri A., Gertz M.A., Kyle R.A., Lacy M.Q., Burritt M.F., Therneau T.M., et al. Serum cardiac troponins and N-terminal pro-brain natriuretic peptide: a staging system for primary systemic amyloidosis. J Clin Oncol 2004, 22:3751-3757.
21. Kumar S., Dispenzieri A., Lacy M.Q., Hayman S.R., Buadi F.K., Colby C., et al. Revised prognostic staging system for light chain amyloidosis incorporating cardiac biomarkers and serum free light chain measurements. J Clin Oncol 2012, 30:989-995.
22. Dubrey S.W., Hawkins P.N., Falk R.H. Amyloid diseases of the heart: assessment, diagnosis, and referral. Heart 2011, 97:75-84.
23. Klein A.L., Hatle L.K., Taliercio C.P., Oh J.K., Kyle R.A., Gertz M.A., et al. Prognostic significance of Doppler measures of diastolic function in cardiac amyloidosis. A Doppler echocardiographic study. Circulation 1991, 83:808-816.
24. Ng B., Connors L.H., Davidoff R., Skinner M., Falk R.H. Senile systemic amyloidosis presenting with heart failure: a comparison with light chain-associated amyloidosis. Arch Intern Med 2005, 165:1425-1429.
25. Kapoor P., Thenappan T., Singh E., Kumar S., Greipp P.R. Cardiac amyloidosis: a practical approach to diagnosis and management. Am J Med 2011, 124:1006-1015.
26. Kyle R.A., Gertz M.A., Greipp P.R., Witzig T.E., Lust J.A., Lacy M.Q., et al. Long-term survival (10 years or more) in 30 patients with primary amyloidosis. Blood 1999, 93:1062-1066.